Pathogenic bacteria suppression via bacteriocin production

The entry "Pathogenic bacteria suppression via bacteriocin production" does **not** refer to a single molecule or receptor but rather describes a biological process mediated by various antimicrobial peptides called **bacteriocins**. Bacteriocins are ribosomally synthesized peptides or proteins produced by many bacterial species—especially lactic acid bacteria—that inhibit the growth of closely related or even broad-spectrum pathogenic bacteria through mechanisms such as pore formation in target cell membranes or enzymatic degradation of cell wall components. Their synthesis is tightly regulated at the genetic level—often involving quorum sensing systems—and they play an important role both ecologically (microbial competition) and therapeutically/prophylactically (food safety, infection prevention). Notable examples include nisin from Lactococcus lactis and plantaricins from Lactiplantibacillus plantarum. While widely used as natural preservatives and explored for therapeutic applications against infections, "bacteriocin production" itself is not considered a canonical drug target like an enzyme or receptor but rather represents an antimicrobial strategy employed by certain probiotic strains.

Other names

Bacteriocin-mediated pathogen inhibitionBacteriocin-based bacterial suppressionAntimicrobial peptide-mediated pathogen control

Bactericidal or bacteriostatic action via pore formation in bacterial membranes, dissipation of membrane potential, ATP efflux leading to cell death; some degrade cell walls or membranes; often regulated by quorum sensing systems and specific gene operons for synthesis and immunity proteins